Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Phase 2

Completed

Conditions: Urothelial Carcinoma
Cancer
Myeloproliferative Disorder

Interventions: Drug: Bevacizumab
Drug: Carboplatin
Drug: Gemcitabine

First Posted Date: 2008-01-08

Last Posted Date: 2016-01-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT00588666

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow, New York, United States

and more 3 locations

Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Phase 2

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary PERITONEUM

Interventions: Drug: Paclitaxel,Cisplatin, Bevacizumab

First Posted Date: 2008-01-08

Last Posted Date: 2016-01-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT00588237

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

Phase 1

Completed

Conditions: Cervical Cancer
Uterine Cancer
HEENT Cancer
RECTUM
Renal Cancer
CERVIX UTERI NOS

Interventions: Radiation: 124I-Iodo-Azomycin Galacto-Pyranoside

First Posted Date: 2008-01-08

Last Posted Date: 2015-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT00588276

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning

Phase 1

Completed

Conditions: Lung Cancer
Non-Hodgkin's Lymphoma

Interventions: Device: PET/CT scan

First Posted Date: 2008-01-08

Last Posted Date: 2015-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT00588328

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer

Withdrawn

Conditions: Extrahepatic Bile Duct Cancer
Gallbladder Cancer
OVARY
Lung Cancer
CORPUS UTERI,ENDOMETRIUM
Non-Hodgkin's Lymphoma
Uterine Cancer
Gastric Cancer
Melanoma
LUNG

First Posted Date: 2008-01-08

Last Posted Date: 2018-02-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00588263

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Recruiting

Conditions: Neuroblastoma

Interventions: Other: Tumor and Marrow Markers

First Posted Date: 2008-01-08

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1500

Registration Number: NCT00588068

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Quantification of Breast Sensation Following Postmastectomy Breast Reconstruction

Completed

Conditions: Breast Cancer
Cancer

Interventions: Behavioral: breast exam and questionaire

First Posted Date: 2008-01-08

Last Posted Date: 2021-04-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 153

Registration Number: NCT00588419

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

Phase 2

Completed

Conditions: Langerhans Cell Histiocytosis

Interventions: Drug: Methotrexate
Drug: 6-Thioguanine
Drug: Leucovorin Calcium

First Posted Date: 2008-01-08

Last Posted Date: 2015-05-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5

Registration Number: NCT00588536

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla

Not Applicable

Completed

Conditions: Prostate Cancer
MRI

Interventions: Other: Magnetic Resonance Imaging; Spectroscopic Imaging, Contrast Enhanced Imaging

First Posted Date: 2008-01-08

Last Posted Date: 2019-03-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 265

Registration Number: NCT00588679

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

Phase 2

Completed

Conditions: CNS Cancer
CNS BRAIN

Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa

First Posted Date: 2008-01-08

Last Posted Date: 2023-10-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT00588523

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy